FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

InvaGen Pharmaceuticals Testosterone Topical Solution 30mg of Recall

Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation…

InvaGen Pharmaceuticals, Inc. · Central Islip, NY

Risk level
Class III
Reported by FDA
Jul 10, 2019
Recall ID
D-1454-2019
Check your lot numberHow we source this data

Summary

InvaGen Pharmaceuticals recalled Testosterone Topical Solution 30mg of starting Jun 12, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1454-2019 on Jul 10, 2019. Reason: Defective Container; actuator may improperly function and affect dose delivery. Status: Terminated.

Why it was recalled

Defective Container; actuator may improperly function and affect dose delivery.

Product description

Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-44

Lot numbers, UPCs & expiration codes

Lot GH80480 and GH80481, exp 3/2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1454-2019
Classification
Class III
Status
Terminated
Recall initiated
Jun 12, 2019
FDA report date
Jul 10, 2019
Quantity
1776 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
InvaGen Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1454-2019, exactly as published.

Show all FDA fields
City
Central Islip
State
NY
Status
Terminated
Country
United States
Event ID
83117
Address
550 S Research Pl
Code information
Lot GH80480 and GH80481, exp 3/2020
Postal code
11722-4415
Report date
Jul 10, 2019
Product type
Drugs
Recall number
D-1454-2019
Classification
Class III
Recalling firm
InvaGen Pharmaceuticals, Inc.
Product quantity
1776 bottles
Termination date
Jan 28, 2021
Reason for recall
Defective Container; actuator may improperly function and affect dose delivery.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-44
Distribution pattern
Nationwide
Recall initiation date
Jun 12, 2019
Initial firm notification
Letter
Center classification date
Jul 3, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1454-2019, published Jul 10, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls